Michelle Mazei-Robison is an Associate Professor in the Department of Physiology and Neuroscience Program at Michigan State University. Dr. Mazei-Robison graduated with a B.S. in Biology and Chemistry from Central Michigan University in 1999 and a Ph.D. in Pharmacology from Vanderbilt University in 2005. Following a post-doctoral fellowship at UT Southwestern and Icahn School of Medicine at Mount Sinai, she joined Michigan State University as an Assistant Professor in 2012. Her lab is focused on identifying novel mechanisms that underlie neuropsychiatric disorders such as depression and substance use disorder. Her work focuses on changes in ventral tegmental area dopamine neuron signaling, morphology, and activity and has resulted in over 55 peer-reviewed publications and book chapters. Her studies have been primarily funded by NIH, but she has also received research awards from the PhRMA Foundation and Peter F. McManus Charitable Trust. Dr. Mazei-Robison has also garnered early career awards from the American College of Neuropsychopharmacology (ACNP), the American Society for Pharmacology and Experimental Therapeutics (ASPET), and the Teacher-Scholar Award from the College of Natural Science at MSU. Dr. Mazei-Robison is a dedicated research mentor and she has supervised over 25 undergraduate and graduate students and served on 30 thesis committees. Her trainees have earned numerous prestigious fellowships including awards from HHMI, NIH, and the PhRMA Foundation, over 20 travel awards to present their work at national conferences, and they have gone on to academic and non-profit scientific positions as well as medical and graduate training programs. Dr. Mazei-Robison has also been actively involved in scientific societies including the ASPET Neuropharmacology Division, ACNP, and the Catecholamine Society, for which she currently serves as Treasurer. She was appointed as Associate Chair of the Department of Physiology in 2021.